University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: nab-paclitaxel
Drug: trastuzumab
Drug: Doxorubicin
Drug: cyclophosphamide
Biological: Growth Factor Support
Procedure: Surgery

First Posted Date: 2009-07-22

Last Posted Date: 2018-04-23

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 32

Registration Number: NCT00944047

Locations: 🇺🇸
University of Kansas Medical Center Cancer Center, Kansas City, Kansas, United States
🇺🇸
Hays Medical Center, Hays, Kansas, United States

A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Phase 1

Terminated

Conditions: Renal Cell Carcinoma

Interventions: Drug: Bevacizumab
Drug: Azacitidine

First Posted Date: 2009-07-08

Last Posted Date: 2017-06-14

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 11

Registration Number: NCT00934440

Locations: 🇺🇸
Stormont-Vail Cotton O'Neil Cancer Center, Topeka, Kansas, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Does Peri-Operative Gabapentin Reduce Chronic Post-Thoracotomy Pain?

Phase 3

Withdrawn

Conditions: Post-thoracotomy Pain

Interventions: Drug: Placebo
Drug: Gabapentin

First Posted Date: 2009-07-08

Last Posted Date: 2015-12-16

Lead Sponsor: University of Kansas Medical Center

Registration Number: NCT00934193

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

Phase 2

Completed

Conditions: Invasive Breast Cancer

Interventions: Drug: Fulvestrant
Drug: Anastrazole

First Posted Date: 2009-06-16

Last Posted Date: 2023-05-19

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 42

Registration Number: NCT00921115

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Physical Activity and Glycemic Control

Not Applicable

Completed

Conditions: Insulin Resistance

Interventions: Behavioral: Exercise

First Posted Date: 2009-04-16

Last Posted Date: 2015-09-24

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 12

Registration Number: NCT00881972

Locations: 🇺🇸
University of Missouri-Columbia, Columbia, Missouri, United States

Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma

Phase 2

Completed

Conditions: Non-Hodgkins Lymphoma

Interventions: Drug: Rituximab

First Posted Date: 2009-03-05

Last Posted Date: 2017-05-30

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 21

Registration Number: NCT00856245

Locations: 🇺🇸
University of Kansas Medical Center, Westwood Campus, Kansas City, Kansas, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: acolbifene hydrochloride

First Posted Date: 2009-03-02

Last Posted Date: 2018-01-17

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 25

Registration Number: NCT00853996

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Efficacy of Methotrexate in Myasthenia Gravis

Phase 2

Completed

Conditions: Myasthenia Gravis

Interventions: Drug: Methotrexate
Other: Placebo

First Posted Date: 2008-12-24

Last Posted Date: 2016-05-26

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 50

Registration Number: NCT00814138

Locations: 🇺🇸
University of California-Irvine, Irvine, California, United States
🇺🇸
Penn State College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

and more 13 locations

Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Not Applicable

Terminated

Conditions: Epistaxis

Interventions: Drug: Merocel pack
Drug: Thrombin-JMI

First Posted Date: 2008-12-24

Last Posted Date: 2016-01-15

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 1

Registration Number: NCT00814333

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy

Phase 2

Terminated

Conditions: Metastatic Breast Cancer

Interventions: Drug: lapatinib

First Posted Date: 2008-09-25

Last Posted Date: 2019-07-01

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 33

Registration Number: NCT00759642

Locations: 🇺🇸
Truman Medical Center, Kansas City, Missouri, United States
🇺🇸
Cotton-O-Neil Cancer Center (Stormont Vail Health Care), Topeka, Kansas, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy